Eos Advisory
Investor profile
Venture capital
Eos Advisory has backed 13 European tech companies across 15 funding rounds between 2022 and 2026, joining rounds totalling €73M. Most active in Healthtech and Cleantech. Data as of Nov 2026.
Also recorded as: Eos Advisory LLP
Deals
15
distinct rounds
Companies
13
backed
Active span
2022–2026
5 yrs
Total round €
€73M
sum of rounds joined
Deals by year
distinct rounds / yearEos Advisory — deals by year — interactive chart.
Data table
| Eos Advisory — deals by year | |
|---|---|
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 2 |
Top sectors
by dealsEos Advisory — top sectors — interactive chart.
Data table
| Eos Advisory — top sectors | |
|---|---|
| Healthtech | 12 |
| Cleantech | 2 |
| Deeptech | 1 |
Stages
by dealsEos Advisory — stages — interactive chart.
Data table
| Eos Advisory — stages | |
|---|---|
| Seed | 7 |
| Other | 6 |
| Series A | 2 |
Countries
by dealsEos Advisory — countries — interactive chart.
Data table
| Eos Advisory — countries | |
|---|---|
| UK | 15 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Scottish Enterprise6
- Maven Capital Partners3
- Old College Capital3
- Archangels2
- Calculus Capital2
- Hanna Capital SEZC2
- Investment Fund for Scotland (IFS)2
- Mercia Ventures2
- Norcliffe Capital2
- SIS Ventures2
- Adeline Arts & Science1
- AFI Ventures1
- Alba Equity1
- CDP Venture Capital1
- chANGELS1
- Conduit Connect1
- Eli lilly and company1
- Empirical Ventures1
- European Innovation Council (EIC)1
- EverQuest Capital Partners1
- Exergon1
- Gabriel Investment Syndicate1
- Heartfelt1
- HERmesa1
- InnoEnergy1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Bioliberty | UK | 2 | €11M |
| Dxcover | UK | 1 | €11M |
| Naturbeads | UK | 2 | €11M |
| Laverock Therapeutics | UK | 1 | €7.6M |
| TaiSan | UK | 1 | €5.4M |
| EnsiliTech | UK | 1 | €5.2M |
| Carcinotech | UK | 1 | €4.9M |
| Nami Surgical | UK | 1 | €3.7M |
| Concinnity | UK | 1 | €3.6M |
| Green Bioactives | UK | 1 | €3.0M |
| Neupulse | UK | 1 | €2.9M |
| Waire Health | UK | 1 | €2.3M |
| Chromacity | UK | 1 | €1.2M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Dxcover | Series A | €11M | 2023-02 |
| Naturbeads | Series A | €9.4M | 2024-11 |
| Bioliberty | Other | €8.8M | 2026-03 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
| TaiSan | Seed | €5.4M | 2026-07 |
| EnsiliTech | Seed | €5.2M | 2025-08 |
| Carcinotech | Other | €4.9M | 2024-01 |
| Nami Surgical | Seed | €3.7M | 2024-05 |
| Concinnity | Seed | €3.6M | 2024-12 |
| Green Bioactives | Seed | €3.0M | 2022-12 |